Catalyst Wire Dossier Catalyst Wire Dossier

HGF plasmid vector (gene therapy approach)

hepatocyte growth factor plasmid · AnGes USA, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HGF plasmid vector (gene therapy approach), covering 2011-08-19 to 2011-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers [Phase 2]

See pricing